Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
ECG Quote, Financials, Valuation and Earnings
Last price:
$89.81
Seasonality move
:
-43.84%
Day range:
$88.93 - $90.52
52-week range:
$31.38 - $103.08
Dividend yield:
0%
P/E ratio:
25.31x
P/S ratio:
1.31x
P/B ratio:
7.98x
Volume:
168.8K
Avg. volume:
578.3K
1-year change:
27.03%
Market cap:
$4.6B
Revenue:
$2.8B
EPS (TTM):
$3.54
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $2.1B | $2.7B | $2.9B | $2.8B | |
| Revenue Growth (YoY) | -- | -- | 31.57% | 5.75% | -0.17% | |
| Cost of Revenues | -- | $1.8B | $2.4B | $2.5B | $2.5B | |
| Gross Profit | -- | $245.4M | $273.8M | $319.8M | $337.6M | |
| Gross Profit Margin | -- | 11.96% | 10.15% | 11.21% | 11.85% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $102.2M | $111.4M | $131.4M | $149.5M | |
| Other Inc / (Exp) | -- | $1.7M | $1.4M | $4M | $4.9M | |
| Operating Expenses | -- | $99.7M | $109.2M | $129.3M | $147.7M | |
| Operating Income | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Net Interest Expenses | -- | $3.5M | $6.5M | $17M | $14M | |
| EBT. Incl. Unusual Items | -- | $144M | $159.7M | $177.6M | $180.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $35.4M | $40.8M | $45.3M | $49.5M | |
| Net Income to Company | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Basic EPS (Cont. Ops) | -- | $2.15 | $2.45 | $2.69 | $2.81 | |
| Diluted EPS (Cont. Ops) | -- | $2.15 | $2.45 | $2.69 | $2.81 | |
| Weighted Average Basic Share | -- | $51M | $51M | $51M | $51M | |
| Weighted Average Diluted Share | -- | $51M | $51M | $51M | $51M | |
| EBITDA | -- | $166M | $186.1M | $213.7M | $215.2M | |
| EBIT | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Revenue (Reported) | -- | $2.1B | $2.7B | $2.9B | $2.8B | |
| Operating Income (Reported) | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Operating Income (Adjusted) | -- | $145.8M | $164.6M | $190.5M | $189.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $717.4M | $761M | $986.8M | |
| Revenue Growth (YoY) | -- | -- | -- | 6.08% | 29.68% | |
| Cost of Revenues | -- | -- | $633M | $671.6M | $862.6M | |
| Gross Profit | -- | -- | $84.4M | $89.4M | $124.2M | |
| Gross Profit Margin | -- | -- | 11.76% | 11.75% | 12.59% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $34.8M | $36.2M | $51.8M | |
| Other Inc / (Exp) | -- | -- | $1.2M | $1.1M | -- | |
| Operating Expenses | -- | -- | $34.3M | $35.7M | $50.7M | |
| Operating Income | -- | -- | $50.1M | $53.7M | $73.5M | |
| Net Interest Expenses | -- | -- | $4.6M | $2.9M | $5.4M | |
| EBT. Incl. Unusual Items | -- | -- | $46.7M | $51.9M | $72.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $11.4M | $14M | $20.6M | |
| Net Income to Company | -- | -- | $36M | $41.8M | $57M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $36M | $41.8M | $57M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.71 | $0.82 | $1.12 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.71 | $0.82 | $1.11 | |
| Weighted Average Basic Share | -- | -- | $51M | $51M | $51M | |
| Weighted Average Diluted Share | -- | -- | $51M | $51M | $51.1M | |
| EBITDA | -- | -- | $56M | $60M | $80.8M | |
| EBIT | -- | -- | $50.1M | $53.7M | $73.5M | |
| Revenue (Reported) | -- | -- | $717.4M | $761M | $986.8M | |
| Operating Income (Reported) | -- | -- | $50.1M | $53.7M | $73.5M | |
| Operating Income (Adjusted) | -- | -- | $50.1M | $53.7M | $73.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.1B | $3.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $1.8B | $3.1B | |
| Gross Profit | -- | -- | $173.1M | $256.7M | $422.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $69.8M | $102.3M | $181M | |
| Other Inc / (Exp) | -- | -- | $2M | $5M | -- | |
| Operating Expenses | -- | -- | -- | $61.9M | $178.1M | |
| Operating Income | -- | -- | -- | $194.8M | $244.3M | |
| Net Interest Expenses | -- | -- | $9.8M | $9.6M | $20.7M | |
| EBT. Incl. Unusual Items | -- | -- | $128.8M | $187.5M | $230.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $40.1M | $65.5M | |
| Net Income to Company | -- | -- | -- | -- | $181M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $117.2M | $181M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $2.30 | $3.55 | |
| Diluted EPS (Cont. Ops) | -- | -- | $1.46 | $2.30 | $3.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $275.1M | $272.4M | |
| EBIT | -- | -- | -- | $194.8M | $244.3M | |
| Revenue (Reported) | -- | -- | -- | $2.1B | $3.5B | |
| Operating Income (Reported) | -- | -- | -- | $194.8M | $244.3M | |
| Operating Income (Adjusted) | -- | -- | -- | $194.8M | $244.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.5B | $1.5B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $1.3B | $1.3B | $2.4B | |
| Gross Profit | -- | -- | $173.1M | $177.5M | $336.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $69.8M | $73.5M | $140.7M | |
| Other Inc / (Exp) | -- | -- | $2M | $3.7M | $567K | |
| Operating Expenses | -- | -- | $33.5M | $33.6M | $138.2M | |
| Operating Income | -- | -- | $139.6M | $143.9M | $198.3M | |
| Net Interest Expenses | -- | -- | $9.8M | $6.1M | $15.5M | |
| EBT. Incl. Unusual Items | -- | -- | $128.8M | $138.8M | $188.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $24.6M | $27.6M | $53.6M | |
| Net Income to Company | -- | -- | $100.7M | $41.8M | $146.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $74.7M | $80.7M | $146.5M | |
| Basic EPS (Cont. Ops) | -- | -- | $1.46 | $1.58 | $2.87 | |
| Diluted EPS (Cont. Ops) | -- | -- | $1.46 | $1.58 | $2.87 | |
| Weighted Average Basic Share | -- | -- | $152.9M | $152.9M | $153.1M | |
| Weighted Average Diluted Share | -- | -- | $152.9M | $152.9M | $153.3M | |
| EBITDA | -- | -- | $213.9M | $218.3M | $219.6M | |
| EBIT | -- | -- | $139.6M | $143.9M | $198.3M | |
| Revenue (Reported) | -- | -- | $1.5B | $1.5B | $2.7B | |
| Operating Income (Reported) | -- | -- | $139.6M | $143.9M | $198.3M | |
| Operating Income (Adjusted) | -- | -- | $139.6M | $143.9M | $198.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $2.1M | $1.6M | $86M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $730.2M | $655.9M | $757.1M | |
| Inventory | -- | -- | $36.8M | $42.7M | $43.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $13.3M | $17.7M | $30.4M | |
| Total Current Assets | -- | -- | $788.1M | $729.3M | $917.2M | |
| Property Plant And Equipment | -- | -- | $163.2M | $169.3M | $201.5M | |
| Long-Term Investments | -- | -- | $22.9M | $8.4M | $21.3M | |
| Goodwill | -- | -- | $143.2M | $143.2M | $143.2M | |
| Other Intangibles | -- | -- | $4.1M | $2M | $116K | |
| Other Long-Term Assets | -- | -- | $11.2M | $272K | $5.2M | |
| Total Assets | -- | -- | $1.1B | $1.1B | $1.3B | |
| Accounts Payable | -- | -- | $138.1M | $116.3M | $137.7M | |
| Accrued Expenses | -- | -- | $50.8M | $48.3M | $52M | |
| Current Portion Of Long-Term Debt | -- | -- | $27M | -- | $15M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $20M | $21.1M | $26.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $473.7M | $394.1M | $513.4M | |
| Long-Term Debt | -- | -- | $258.3M | $201M | $321.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $753.3M | $640.5M | $910.1M | |
| Common Stock | -- | -- | $1K | $1K | $510K | |
| Other Common Equity Adj | -- | -- | -$35K | -- | -- | |
| Common Equity | -- | -- | $382.2M | $448.8M | $422.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $382.2M | $448.9M | $422.6M | |
| Total Liabilities and Equity | -- | -- | $1.1B | $1.1B | $1.3B | |
| Cash and Short Terms | -- | -- | $2.1M | $1.6M | $86M | |
| Total Debt | -- | -- | $285.3M | $201M | $336.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $553K | $149.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $800M | $986.7M | |
| Inventory | -- | -- | -- | $46.9M | $48M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $20.6M | -- | |
| Total Current Assets | -- | -- | -- | $886.5M | $1.2B | |
| Property Plant And Equipment | -- | -- | -- | $198.2M | $235M | |
| Long-Term Investments | -- | -- | -- | $50.5M | $25.7M | |
| Goodwill | -- | -- | -- | $143.2M | -- | |
| Other Intangibles | -- | -- | -- | $466K | -- | |
| Other Long-Term Assets | -- | -- | -- | $360K | -- | |
| Total Assets | -- | -- | -- | $1.3B | $1.6B | |
| Accounts Payable | -- | -- | -- | $160.6M | $212.8M | |
| Accrued Expenses | -- | -- | -- | $54.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $26.1M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $559.6M | $691.9M | |
| Long-Term Debt | -- | -- | -- | $257.8M | $323.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $826M | $1.1B | |
| Common Stock | -- | -- | -- | $1K | $510K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $453.3M | $573M | |
| Total Liabilities and Equity | -- | -- | -- | $1.3B | $1.6B | |
| Cash and Short Terms | -- | -- | -- | $553K | $149.2M | |
| Total Debt | -- | -- | -- | $257.8M | $338.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $109.4M | $124.8M | $137.2M | $143.4M | |
| Depreciation & Amoritzation | -- | $20.3M | $21.5M | $23.1M | $25.3M | |
| Stock-Based Compensation | -- | $1.7M | $1.1M | $804K | $1.6M | |
| Change in Accounts Receivable | -- | -$12.8M | -$239.9M | $45.3M | -$89.7M | |
| Change in Inventories | -- | -$2.1M | -$15.8M | -$5.9M | -$1M | |
| Cash From Operations | -- | $86.2M | -$22.4M | $174.1M | $165.5M | |
| Capital Expenditures | -- | $27.3M | $35.8M | $35.6M | $48.3M | |
| Cash Acquisitions | -- | $2.5M | -- | -- | -- | |
| Cash From Investing | -- | $924K | -$24.6M | -$20M | -$37.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $27M | -- | $340M | |
| Long-Term Debt Repaid | -- | -$7K | -- | -$72M | -$40M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$87.8M | $24.5M | -$79.9M | -$341.9M | |
| Cash From Financing | -- | -$88.5M | $48.4M | -$154.7M | -$44M | |
| Beginning Cash (CF) | -- | $2.1M | $2.1M | $1.6M | $86M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$1.4M | $1.4M | -$545K | $84.4M | |
| Ending Cash (CF) | -- | $668K | $3.6M | $1M | $170.5M | |
| Levered Free Cash Flow | -- | $58.9M | -$58.2M | $138.6M | $117.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $36M | $41.8M | $57M | |
| Depreciation & Amoritzation | -- | -- | $5.9M | $6.3M | $7.3M | |
| Stock-Based Compensation | -- | -- | $295K | $345K | $1.9M | |
| Change in Accounts Receivable | -- | -- | $21M | -$24.3M | -$67M | |
| Change in Inventories | -- | -- | -$5.7M | $1.7M | $95K | |
| Cash From Operations | -- | -- | $80.8M | $80.5M | $76.2M | |
| Capital Expenditures | -- | -- | $7.8M | $18M | $10.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$4.6M | -$14M | -$8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$72M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $25.5M | -$64.7M | -- | |
| Cash From Financing | -- | -- | -$76.2M | -$66.3M | -$3.8M | |
| Beginning Cash (CF) | -- | -- | $2.1M | $553K | $149.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$59K | $231K | $64.5M | |
| Ending Cash (CF) | -- | -- | $553K | $784K | $213.6M | |
| Levered Free Cash Flow | -- | -- | $73M | $62.5M | $65.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $181M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $28.1M | |
| Stock-Based Compensation | -- | -- | $739K | $1M | $5.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$211M | |
| Change in Inventories | -- | -- | -- | -- | -$1M | |
| Cash From Operations | -- | -- | -- | -- | $191.5M | |
| Capital Expenditures | -- | -- | $7.8M | $25.4M | $55.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$45.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $2.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $148.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $29.8M | $135.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $100.7M | $41.8M | $146.5M | |
| Depreciation & Amoritzation | -- | -- | $17.2M | $6.3M | $21.3M | |
| Stock-Based Compensation | -- | -- | $517K | $345K | $4.8M | |
| Change in Accounts Receivable | -- | -- | -$49.2M | -$24.3M | -$235.6M | |
| Change in Inventories | -- | -- | -$9M | $1.7M | -$4.2M | |
| Cash From Operations | -- | -- | $62.3M | $80.5M | $108.6M | |
| Capital Expenditures | -- | -- | $28.1M | $18M | $42.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$16.4M | -$14M | -$33.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$144M | -- | -$3.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $126.3M | -$58.2M | -$588K | |
| Cash From Financing | -- | -- | -$47.4M | -$66.3M | -$11.8M | |
| Beginning Cash (CF) | -- | -- | $4.2M | $875K | $307.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$1.6M | $231K | $63.2M | |
| Ending Cash (CF) | -- | -- | $1.2M | $784K | $371M | |
| Levered Free Cash Flow | -- | -- | $34.2M | $62.5M | $66.5M | |
Related Companies
Get ECG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ECG
Sector
P/E ratio
25.31x
19.22x
PEG ratio
0.47x
0.18x
P/B ratio
7.98x
1.70x
Price / LTM sales
1.31x
0.85x
Growth Metrics
ECG
Sector
Revenue growth
29.68%
5.02%
Earnings growth
35.98%
5.76%
Revenue (5-year growth)
--
4.27%
Earnings forecast
$0.62
$0.39
Profitability
ECG
Sector
Profitability FY 2024
$337.6M
$253.7M
Return on invested capital
21.65%
4.73%
Return on assets
12.79%
3.1%
Return on equity
37.33%
8.11%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
10
Estimated Next Earnings Date
Feb
3
Balance Sheet
ECG
Sector
Total cash
$149.2M
$139M
Short term investments
--
$32.7M
Total assets
$1.3B
$1.4B
Long term debt
$338.7M
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.5% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 5.12% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
